Page last updated: 2024-10-31

nevirapine and Coronary Artery Disease

nevirapine has been researched along with Coronary Artery Disease in 1 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van der Valk, M1
Kastelein, JJ1
Murphy, RL1
van Leth, F1
Katlama, C1
Horban, A1
Glesby, M1
Behrens, G1
Clotet, B1
Stellato, RK1
Molhuizen, HO1
Reiss, P1

Trials

1 trial available for nevirapine and Coronary Artery Disease

ArticleYear
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile.
    AIDS (London, England), 2001, Dec-07, Volume: 15, Issue:18

    Topics: Adult; Anti-HIV Agents; Coronary Artery Disease; Drug Therapy, Combination; Female; HIV Infections;

2001